Matrix Asset Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$639K Hold
6,175
0.05% 71
2026
Q1
$443K Hold
6,175
0.04% 75
2025
Q4
$490K Sell
6,175
-2
-0% -$158 0.04% 73
2025
Q3
$466K Sell
6,177
-51
-0.8% -$3.5K 0.04% 75
2025
Q2
$430K Buy
6,228
+53
+0.9% +$3.48K 0.04% 74
2025
Q1
$418K Hold
6,175
0.05% 75
2024
Q4
$277K Sell
6,175
-986
-14% -$55.3K 0.03% 93
2024
Q3
$450K Sell
7,161
-11,400
-61% -$665K 0.05% 73
2024
Q2
$1.1M Sell
18,561
-265,183
-93% -$16.6M 0.13% 58
2024
Q1
$22.6M Sell
283,744
-7,410
-3% -$566K 2.71% 14
2023
Q4
$23M Sell
291,154
-15,160
-5% -$1.08M 2.93% 14
2023
Q3
$21.4M Buy
306,314
+1,613
+0.5% +$114K 3.05% 12
2023
Q2
$21.1M Buy
304,701
+6,229
+2% +$443K 2.9% 12
2023
Q1
$22.2M Buy
298,472
+7,123
+2% +$597K 3.21% 11
2022
Q4
$27.2M Sell
291,349
-889
-0.3% -$85.8K 4.07% 4
2022
Q3
$27.9M Sell
292,238
-6,758
-2% -$669K 4.57% 2
2022
Q2
$27.7M Buy
298,996
+54
+0% +$5.27K 4.26% 3
2022
Q1
$30.3M Sell
298,942
-45,709
-13% -$4.8M 4.07% 2
2021
Q4
$35.6M Buy
344,651
+3,219
+0.9% +$297K 4.62% 2
2021
Q3
$29M Buy
341,432
+1,728
+0.5% +$145K 4.08% 3
2021
Q2
$28.3M Sell
339,704
-2,930
-0.9% -$240K 4.07% 3
2021
Q1
$25.8M Buy
342,634
+8,718
+3% +$635K 3.84% 3
2020
Q4
$22.8M Buy
333,916
+1,855
+0.6% +$121K 3.85% 4
2020
Q3
$19.4M Buy
332,061
+6,057
+2% +$377K 3.77% 5
2020
Q2
$21.2M Sell
326,004
-2,861
-0.9% -$180K 4.06% 6
2020
Q1
$19.5M Buy
328,865
+28,778
+10% +$1.92M 4.44% 6
2019
Q4
$22.3M Buy
300,087
+22,178
+8% +$1.56M 3.64% 7
2019
Q3
$17.5M Buy
277,909
+27,742
+11% +$1.64M 3.1% 11
2019
Q2
$13.6M Buy
250,167
+41,479
+20% +$2.23M 2.42% 12
2019
Q1
$11.3M Buy
208,688
+57,290
+38% +$3.54M 1.92% 22
2018
Q4
$9.92M Sell
151,398
-690
-0.5% -$51.5K 1.84% 21
2018
Q3
$12M Sell
152,088
-8,938
-6% -$639K 1.91% 21
2018
Q2
$10.4M Buy
161,026
+8,681
+6% +$572K 1.71% 24
2018
Q1
$9.48M Sell
152,345
-2,476
-2% -$178K 1.56% 26
2017
Q4
$11.2M Sell
154,821
-109,689
-41% -$7.97M 1.78% 23
2017
Q3
$21.5M Sell
264,510
-1,742
-0.7% -$138K 3.54% 8
2017
Q2
$21.4M Buy
266,252
+14,070
+6% +$1.11M 3.67% 6
2017
Q1
$19.8M Buy
252,182
+78,665
+45% +$6.28M 3.48% 7
2016
Q4
$13.7M Buy
173,517
+29,767
+21% +$2.41M 2.32% 17
2016
Q3
$12.8M Buy
143,750
+42,095
+41% +$3.97M 2.26% 16
2016
Q2
$9.73M Sell
101,655
-1,912
-2% -$191K 1.89% 23
2016
Q1
$10.7M Sell
103,567
-3,756
-3% -$365K 2.12% 22
2015
Q4
$10.5M Sell
107,323
-52,088
-33% -$5.1M 2.02% 26
2015
Q3
$15.4M Sell
159,411
-28,670
-15% -$3.01M 2.2% 25
2015
Q2
$19.7M Sell
188,081
-49,113
-21% -$5.02M 2.48% 21
2015
Q1
$24.5M Sell
237,194
-9,103
-4% -$921K 2.83% 11
2014
Q4
$23.7M Sell
246,297
-12,081
-5% -$1.06M 2.68% 19
2014
Q3
$20.6M Sell
258,378
-13,916
-5% -$1.1M 2.39% 24
2014
Q2
$20.5M Sell
272,294
-5,817
-2% -$440K 2.33% 24
2014
Q1
$20.8M Sell
278,111
-8,188
-3% -$578K 2.49% 23
2013
Q4
$20.5M Sell
286,299
-6,853
-2% -$440K 2.49% 20
2013
Q3
$16.6M Sell
293,152
-2,147
-0.7% -$128K 2.24% 25
2013
Q2
$16.9M Buy
+295,299
New +$17.1M 2.36% 25

Other funds holding CVS

Matrix Asset Advisors's CVS Position: Q2 2026 in Review

Matrix Asset Advisors held its CVS Health (CVS) position steady in Q2 2026 at 6,175 shares worth $639K. The position accounts for 0.05% of the portfolio, ranked #71.

Matrix Asset Advisors first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $35.6M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Matrix Asset Advisors held 6,175 shares of CVS Health worth $639K as of Q2 2026.
  • Matrix Asset Advisors left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.05% of Matrix Asset Advisors's portfolio in Q2 2026, its #71 holding.
  • Matrix Asset Advisors first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Matrix Asset Advisors's CVS Health position peaked at $35.6M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Matrix Asset Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.